Vetter to share serialization anti-counterfeiting advice via webinar

Ravensburg, Germany: – Leading contract development and manufacturing organization (CDMO) Vetter Pharma International is to host a free webinar on the use of serialization as an effective way to combat counterfeiting.

The event is being held as regulatory agencies worldwide step up their efforts to identify and implementing new methods to thwart prescription drug counterfeiting of ethical and prescription drugs.

The live webcast starts at 0900 hrs GMT (1100 EDT, 1700 CEST) via the BioProcess International portal (http://www.bpiseminars.com)
For more information and to register click here!

Key serialization questions

The webcast will answer the key questions on the use of serialization, including:

• What are the latest requirements and developments in the market?
• What are the drivers of serialization and where it’s going within the biopharmaceutical industry?
• What is required to implement serialization successfully?
• How can a CDMO meet changes in customer requirements and updates in regulatory standards during a project run?
• What are the best ways to integrate serialization equipment components into existing packaging lines?

Anti-counterfeiting fight back

The webinar will be hosted by two of the company’s experts, Product and Service Manager Daniela Guttmann and Alexander Ulbrich, Serialization Project Manager (IT) for Vetter.

“Even without current regulatory moves, the industry has become increasingly concerned about the damage being done by increased counterfeiting and determined to fight back,” she noted.

“Serialization provides a primary weapon against the pirates and seems to revolutionize manufacturing and packaging processes over the next couple of years,” said Daniela.

About Vetter

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Its clientele includes the world’s ten largest pharma/biotech firms.

A full-service provider, Vetter supports products throughout their lifecycles, from preclinical development through global market supply. Through its U.S. and European facilities, Vetter Development Service provides state-of-the-art support for early-stage products, with seamless transfer at Phase III to Vetter Commercial Manufacturing for large-scale production. Vetter employs approximately 3,300 staff across Europe and the United States.

For more information about Vetter, visit www.vetter-pharma.com

About the Presenters

Daniela Guttmann

Product and service manager Daniela joined Vetter in 2011 and is currently responsible for the secondary packaging, serialization and sterile water for injection services. She holds a MBA in International Business Development from the ESB Business School Reutlingen, Germany. She started her career path in the pharmaceutical industry in 2003 contributing to different areas of the business in Latin America and Europe.

Alexander Ulbrich

Alexander is project manager within the IT department responsible for the Serialization Project at Vetter. He joined the company in 2003 and since 2013 has been team leader responsible for a team of SAP application consultants. Prior to Vetter, Alexander was with the technology group of Acterna (now JDSU) as system administrator member of the global Lotus Notes Core Team. After he finished his studies at the FH Reutlingen he began his working career in 1999 at Wavetek Wandel und Goltermann as a qualified engineer (FH) of Electronics.